World News – USA – Black Friday & Cyber ​​Monday Massage Chairs Deals (2020): Top sales of & massage chairs by La-Z-Boy listed by The Consumer Post

0
11

. .

Black Friday Massage Chair & La-Z-Boy Deals are underway for 2020, check out the best Black Friday & Cyber ​​Monday Padded & Shiatsu Massage Chair Deals below

Black Friday & Cyber ​​Monday massage chair offers have arrived. Find the best discounts on La-Z-Boy loungers, Shiatsu massage chairs, padded massage chairs, and more. Access the best deals using the links below.

Save up to 53% on a wide variety of massage chairs at Walmart – click the link for great deals on massage chairs with Shiatsu and padded & La-Z-Boy features.

Save up to $ 100 on top-notch massage chairs on Amazon – check live prices on OWAYS, BestMassage & SMAGREHOE massage chairs

Save up to $ 525 on lounge chairs and portable massage chairs at Target. com – Find out the latest prices of lounge chairs, portable massage chairs

Save money on Shiatsu massage chairs at Belk. com – equipped with Smartsense technology to identify the body’s pressure points and provide pain relief and pressure relief

Save on & massage chairs made of synthetic leather at Staples. com – check live prices for leather massage chairs, portable massage chairs, massage chairs, and more

Save up to $ 200 on Shiatsu Massage Chairs on Amazon – check out the latest deals on Shiatsu Massage Chairs with Full Body and Neck & Backs

Save up to $ 50 on Padded Massage Chairs on Amazon – see great deals on Padded Suede Massage Chairs, & Suede Fabric

Save up to 50% on modern massage chairs at Walmart – click the link for the latest discounts on modern massage chairs from top brands like Topcobe, COSTWAY, & BestMassage

Save up to 45% on recliners from brands like Flash Furniture and more at Walmart – including deals on reclining massage chairs, home theater recliners, and children’s recliners

Save up to $ 30 on relaxing loungers from Christopher Knight Home, Esright, and other suppliers on Amazon. Click the link to see the latest deals on lounge chairs for your living room or home theater.

Save up to $ 131 on a variety of beds from brands like Baby Relax at Target. com – Check live prices for lounge chairs, including leather armchairs, massage chairs, gliders, and seesaws

Save up to $ 233 on loungers from Christopher Knight Home, Abbyson, and more at Overstock. com – includes discounts on seesaws, gliders, and loungers with lifting aid

Save up to 25% on first-class ProLounger loungers at Belk. com – Check live prices for push-back, lift, rocker and power beds

Are you looking for other offers? Check out Walmart’s Black Friday & Cyber ​​Monday deal and Amazon Black Friday & Cyber ​​Monday deal to compare even more active deals. Consumer Post earns commissions from purchases made through the links provided.

About consumer mail: Consumer mail communicates news for online shoppers. As an Amazon Associate and Affiliate, The Consumer Post makes qualifying purchases.

Dow Jones futures fell Thursday as AstraZeneca said another coronavirus vaccine study is likely to be conducted. One key measure suggests that investors are becoming overly optimistic.

When a stock starts to fall, investors need to ask two questions. First, why is it falling? Something wrong? Or is it just facing a storm of circumstance but is otherwise healthy? When the latter is the case, the second question comes into play. Has this stock bottomed out? When a solid stock hits the bottom, it’s a signal for investors to buy in. You can’t go wrong buying cheap and selling high, but you need to know when low is happening. Otherwise, you could miss your chance to maximize profits. Wall Street analysts make a name for themselves by getting stocks right. Recently, some of these analysts have been citing several obvious down-and-out stocks as prime candidates for strong earnings. These are stocks that fit a profile based on TipRanks data: every stock has had tough times in 2020; Everyone has an average uptrend starting north of 40%, and everyone has at least one analyst who says they are likely to make radical gains in 2021. Benefitfocus (BNFT) We start in the world of benefit management, an important sector that affects a number of areas. Employers, insurance brokers, health insurers, and retail partnerships offer various types of benefits to consumers – and Benefitfocus offers a technical solution that simplifies the management of benefits. The company offers a software platform specifically designed for the HR and data aspects of benefit programs, from registration to management. However, this niche can be a double-edged sword. In good times with swinging benefit programs, everyone will feel like it – but in bad times Benefitfocus was not able to regain momentum. The company’s stock is down 42% year-to-date, and third-quarter results showed continued year-over-year losses. Revenue is down 11% year over year to $ 63. 6 million, with declines in all of the company’s major segments: software sales, subscription sales, and platform sales. At the same time there were positive developments. Lincoln Financial Group and PayActive joined Benefitfocus as catalog suppliers, and the company had its first open registration with the University of Texas system. The company ended the third quarter with $ 176 million in cash. These quarterly results came when Benefitfocus introduced a new management. The company announced Stephen Swad as its new CEO. His position as CFO was filled by Alpana Wegner. The company also announced new hires for the positions of Chief Data Officer and EVP, Product & Engineering. These are important steps that mean a new outlook at the top. 5-star analyst Sean Wieland reports on BNFT about this stock for Piper Sandler: “With the new management at the top, we are feeling a renewed energy that is driving the business forward. SaaS offerings are a focus area that focuses on the B2B2C channel while removing direct contact with the consumer business. The health of this customer base continues to be above expectations, with a positive benefit from large workers, which increases net rationale 8. 3% year-on-year up to 18. 2M. OEP fits into this positive narrative as mgmt is happy with the progress made so far and sees continued strength as the sales season progresses. « Wieland’s optimistic outlook is also supported by his overweight (i. e. Buy) Rating and $ 29 Target Price, implying an upward trend of 132% for a year. (To see Wieland’s track record, click here. ) Overall, Wall Street seems to agree with Wieland on BNFT. The stock has a strong buy consensus rating based on 3 buy ratings and 1 hold. The shares sell for $ 12. 50 and the average target price at $ 17. 67, suggests room for an uptrend of 41% over the next 12 months. (See BNFT stock analysis on TipRanks) Momo, Inc. . (MOMO) Next up is Momo, the Chinese mobile social media app. This company offers customers a free smartphone app for social posting and instant messaging, and monetizes the service through the usual routes of third-party services and paid subscriptions for upgrades. However, Momo has done poorly this year as it has lost 54% since the start of the year. The company’s third fiscal quarter was below expectations with earnings of 30 cents per share and sales of $ 3. 9 billion. Those numbers declined significantly year-on-year, particularly EPS which declined 40% year-over-year. Sales and earnings peaked in the fourth quarter of 19 when the coronavirus broke out – and it has yet to recover. Like BNFT above, Momo had management changes in the third quarter of management. The company has brought on board a new Executive Chairman and a new CEO. Hopefully the new blood will bring new energy to the top. The new CEO, Li Wang, had previously been the company’s COO since 2014. Deutsche Bank’s Leo Chiang admits Momo is in a tough spot but believes the company can set a course. “The Momo app focuses on the content ecosystem, user engagement and community activities to revitalize medium and long tailed users rather than the highest paid cohort whose spending sentiment has been severely affected after the pandemic. The process started in early August and is expected by management to last 6 months. We believe this could lead to healthier long-term prosperity for a social app, ”noted Chiang. Chiang sets a price target of USD 25, which indicates a possible upside potential of 68% in order to meet his buy recommendation. (To see Chiang’s track record, click here. ) The analyst consensus here is a moderate buy based on 8 ratings that include 3 buys and 5 holds. Average target price of the stock of $ 21. 49 indicates an upward movement of 45% from the current share price of $ 14. 83. (See MOMO stock analysis on TipRanks. ) To find great ideas for trading rundown stocks at attractive valuations, visit TipRanks ‘Best Stocks to Buy, a newly launched tool that brings together all of TipRanks’ stock insights. Disclaimer: The opinions expressed in this article are solely those of the presented analysts. The content is intended to be used for informational purposes only. It is very important that you do your own analysis before making any investment.

If you thought about buying the stock for its monster profits on this month’s earth-shattering vaccine news from Pfizer (NYSE: PFE), think again. PFE shares are not a growth game.
Source: Manuel Esteban / Shutterstock. com

It’s a cash flow vehicle.
But don’t take my word for it. Let the market guide you. The tribe immediately rejected Pfizer’s offer to go wild after the news. InvestorPlace – Stock Market News, Stock Advice & Trading Tips
The message was clear. Stay on your trail, little supply. They’re a highly dividend-paying, stable security with a history of shareholder enrichment from these delicious quarterly checks. Maybe one day your price chart turns into a rapid upward trend, but not today.

10 best stocks for investors under 30

This doesn’t mean PFE isn’t a good buy. It is a wonderful candidate for income seekers. But like I said, if you are looking for a quick price hike I am afraid you will be disappointed.
A closer look at PFE Stock
Source: TD Ameritrade’s thinkorswim® platform

The S&P 500 has a dividend yield of 1. 48% and should be considered our base. Companies that offer withdrawals north of 1. 48% are officially interesting as income-generating candidates.
Those who bid less are not worth your time. How does Pfizer compare to the S&P? At 4, it’s almost three times higher. 2%. If you boast a steady stream of income this magnitude, you can be forgiven for not jumping higher with every market rally.
Of course, it would be nice if the income generators grew over time as well. And to be fair, PFE has seen modest growth over the past decade. In recent years, the lion’s share of the return has been achieved through quarterly dividends.
If you want to juicing the return, there are two options available. First, you can increase leverage by buying stocks on margin. For example, let’s say that instead of paying 100% of the storage costs, you only spend 50% of that. The dividend yield of 4. 2% would then double to 8. 4%.
In other words, the traditional investor would 3. Pay $ 620 for 100 shares to receive the $ 1 annual dividend. 52. In contrast, buying margin stocks would only cost 1. Require $ 810 for 100 shares to access the $ 1 annual payout. 52.
However, buying on margin is not without its risks. It is a double edged sword that can accelerate wins and losses. For example, a 50% loss in PFE stock would cause a 100% loss of your capital if you were to acquire stocks with a two-to-one margin.
A second alternative to increasing the return is in the options market with covered calls.
Pfizer Stock Options Beckon
Perhaps the most noticeable difference between using the margin route and using covered calls is leverage. While buying on margin increases risk, selling covered calls decreases risk. You try to increase your returns by making monthly promises to sell your stock at a certain price instead of buying it with money borrowed.
This should appeal more to the conservative, risk-averse investor.
The covered call has many names including buy-write, covered stock, and covered write. Regardless of your preferred nickname, this strategy consists of buying 100 shares and selling a call option. You will receive a bonus in return for the obligation to sell shares.
Typically, traders sell month-long out-of-the-money options. That way, you can take advantage of the stock before you have to sell your shares. In addition, the shorter timeframe results in a higher rate of expiration and greater flexibility in changing the exercise price from month to month.
With PFE at $ 36. 20, you could buy 100 shares and sell the $ 38 call for 55 cents. As long as the stock stays below $ 38, you will earn $ 55 extra income over the next 24 days. And if Pfizer pushes past $ 38, you’ll have to sell the stock for another $ 180 in profit ($ 38- $ 36). 20 x 100 shares).
Here is the bottom line. Pfizer is a cash flow stock that is attractive, but covered calls can make it even better.
At the time of this writing, Tyler Craig held positions (neither directly nor indirectly) in the securities identified in this article.
Click here for a free trial from the world’s best trading community and Tyler’s current home!
More from InvestorPlace

Why everyone is investing in 5G WRONG

Top Stock Picker Reveals Its Next 1. 000% winner

Radical new battery could degrade oil markets

Forget the Vaccine, Buy Pfizer Stock for Its Impressive Cash Flow post first appeared on InvestorPlace.

Electric car shares were sold on news of an investigation in China, while Nikola failed to convince investors of a proposed GM partnership.

Stocks can be cheap for a number of reasons, and not all cheap stocks always offer value. Therefore, investors need to exercise due diligence to find bargain stocks that could also produce solid returns. Today’s article introduces seven of the best cheap stocks that offer value.
Over 80 years ago, the economist Benjamin Graham, who later inspired Warren Buffett, among others, first had the idea of ​​investing in stocks that were sold at a discount to their intrinsic value.
The markets have seen an incredible surge since hitting lows in mid-March. So it may feel like there are no bargains in the universe of robust stocks. However, our markets are large and diverse enough to offer solid companies selling at discounts. Many of these companies usually offer stable dividends as well. InvestorPlace – Stock Market News, Stock Advice & Trading Tips
Investors should ideally not overpay for a company’s growth potential. With that information, here are seven of the best cheap stocks for December:

10 best stocks for investors under 30

AT&T (NYSE: T)
Cisco (NASDAQ: CSCO)
CVS Health (NYSE: CVS)
FedEx (NYSE: FDX)
Fulgent Genetics (NASDAQ: FLGT)
International Gaming Technology (NYSE: IGT)
PPL (NYSE: PPL)

AT&T (T)
Source: Jonathan Weiss / Shutterstock

52 week range: $ 26. 08- $ 39. 55
Dividend yield: 7. 12%
Our first stock on this list of cheap stocks is Dallas, Texas-based technology group AT&T, a global telecommunications, media and entertainment company. So far, T-Shares have fallen over 25% in 2020, bringing the dividend yield to over 7%. . A hefty payout is a big reason for the continued interest in the stock.
AT&T reported a profit for the third quarter at the end of October. Consolidated sales of $ 42. 3 billion showed a decrease of 5. 1% year on year. Five main segments contribute to sales:
Mobility (turnover increases 1st. 1% year-on-year);
Entertainment Group (sales down 10. 2% year-on-year);
Business Wireline (decline in sales 2nd. 5% year-on-year);
WarnerMedia (sales decrease by 10% compared to the previous year);
Latin America (sales decline 19. 3% year-on-year).
Quarterly Adjusted Net Income of $ 2. 8 billion means an EPS of 76 cents. For the year-ago quarter, like-for-like metrics were $ 3. 7 billion and 94 cents. Free cash flow was $ 8. 3 billion.
CEO John Stankey said, “Our strong cash flow for the quarter enables us to continue investing in our growth areas and reducing debt. We now expect free cash flow of $ 26 billion or more for 2020 with a full year dividend payout ratio in the high 50s. . ”
We believe stocks offer an opportunity for capital appreciation and residual income.

Cisco (CSCO)
Source: Diverse Fotografie / Shutterstock. com

52 week range: $ 32. $ 40-50. 28
Dividend yield: 3rd. 38%
Based in San Jose, California, Cisco is focused on networking, communications, security, collaboration, and the cloud. The technology giant helps customers transport data, voice and video traffic.
The group reported the first quarter of fiscal year 21 in November. Sales were $ 11. 9 billion, a 9% decrease from last year compared to $ 13. 2 trillion. Non-GAAP net income was $ 3. 211 billion, which equates to a diluted non-GAAP EPS of 76 cents. Last year it was $ 3 each. 6 billion and 84 cents. Net cash from operations for the quarter was $ 4. 1 billion.
Chuck Robbins, Chairman and CEO, was pleased with the results. CFO Kelly Kramer commented:
Our first quarter results reflect good execution with strong margins in a challenging environment. We continued to transform our business with more software offerings and subscriptions, and increased remaining benefit obligations by 10% year over year. We saw strong growth in operating cash flow and a return of $ 2. 3 billion to shareholders.
Cisco has found it difficult to grow revenue at times over the past few quarters, and its share price reflected the challenge to growth. However, transformation efforts are well advanced as management focuses on software and cloud support services.

7 value stocks that could be fashionable again after the pandemic

Revenue is expected to increase in future quarters due to recurring, high-margin, cloud-related and subscription services.

CVS Health (CVS)
Source: Jonathan Weiss / Shutterstock. com

52 week range: $ 52. 04- $ 77. 03
Dividend yield: 2nd. 92%
CVS Health, based in Rhode Island, is an integrated pharmacy company. As the parent company of CVS Pharmacy, it is the largest pharmacy services group in the United States. The company has been offering Covid-19 tests since spring 4. 000 locations of the CVS pharmacy.
CVS Health operates in three segments: Pharmacy Services, Retail / LTC and Health Care Benefits. The results for the third quarter were published at the beginning of November. Revenue was $ 67. 1 billion, plus 3. 5% year on year. The increase was due to growth in the Health Care Benefits and Retail / LTC segments.
Adjusted earnings per share were $ 1. 66. A year ago it was $ 1. 84, a 21% decrease from $ 1. 17 in the same period last year. The net result also decreased by 20. 3% on $ 1. 22 billion.
Management increased its adjusted EPS guidance for full year 2020 to $ 7. 35- $ 7. 45 of $ 7. 14- $ 7. 27. The cash flow from the operational forecast was also increased to $ 12. $ 75 billion – $ 13. 25 billion from $ 11 to $ 11 billion. 5 billion.
At this point in time, the forward P / E and P / S ratios are 8. 79 and 0. 33 each. We find CVS stocks undervalued and would try to buy the dips in this integrated healthcare powerhouse.

FedEx (FDX)
Source: Antonio Gravante / shutterstock. com

52 week range: $ 88. $ 69-293. 30th
Dividend yield: 0. 89%
FedEx, based in Memphis, Tennessee, provides transportation and logistics services worldwide.
FedEx delivered robust results for the first quarter of fiscal 21 in mid-September. Total non-GAAP revenue was $ 19. 3 billion and rose 13. 5% year on year. Adjusted non-GAAP income was $ 1. 28 billion, 60% more than the same period in FY 20 ($ 800 million). Diluted non-GAAP EPS was $ 4. 87.
Management emphasized, “Operating results increased due to volume growth at FedEx International Priority and U.. . S.. . Domestic parcel services for private households, improved earnings at FedEx Ground and FedEx Freight, as well as an additional operational weekday. These factors have been partially offset by costs to support strong demand and expand services. ”
In other words, the impact of the pandemic on outcomes has been mixed so far. Investors also noted various ongoing charges related to the integration of TNT Express, which FedEx acquired in mid-2016. These costs will affect reported GAAP results and will continue to do so for several more quarters.

7 weak-looking SPACs to avoid right now

The company should benefit from both holiday season sales and international shipments. If you think increased e-commerce activity continues to have a positive impact on parcel carriers like FedEx, keep the stocks on your cheap stocks shopping list.

Fulgent Genetics (FLGT)
Source: Connect world / Shutterstock. com

52 week range: $ 6. $ 70- $ 52. 47
Dividend yield: N / A.
Founded in 2011, California-based Fulgent Genetics develops flexible and affordable genetic testing such as cancer, neonatal and antenatal screening. The tests can also be tailored to customer requirements by combining Next Generation Sequencing (NGS) with its technology platform. In the past few weeks, FDA-authorized Covid-19 test solutions have also been offered to businesses and schools.
Fulgent Genetics released its third quarter results in early November. Record sales of $ 101. 7 million meant an increase of 883% over the previous year. Non-GAAP income for the third quarter of fiscal year was 49 million. And diluted non-GAAP earnings per share are $ 2. 08 per share.
Paul Kim, CFO, quoted: “Our third quarter results represent a major turning point in our business. Our test volume increased by almost 5 year-on-year. 000% and sales by almost 900%. After all, we recorded a deferred turnover of approx. 18 million. USD from 30. September 2020. ”
Investors were happy with these robust sales and earnings metrics. The FLGT share has risen significantly compared to the lows in spring. The business is not very valuable just yet, however, and we would try to buy the dips from this genetic screening company. Fulgent Genetics could also become a takeover candidate in the coming quarters.

International Gaming Technology (IGT)
Source: Shutterstock

52 week range: $ 3. 59- $ 15. 56
Dividend yield: 5th. 96%
The next stock on this list of cheap stocks is from across the Atlantic. International Game Technology, headquartered in London, manufactures and sells computerized gaming devices and software, including slot machines, interactive slot machines and lottery technology. The company works with governments and regulators in over 100 countries.
The group announced its third quarter results in November. Consolidated sales were 982 million. USD, down 15% year over year. International Game Technology reports sales in two segments:
Global Lottery (quarterly sales up 3% year over year);
Global Gaming (quarterly revenue up 31% year over year).
Adjusted net income was 54 million. USD and rose 25%. Adjusted earnings per diluted share were 26 cents compared to 21 cents in the previous year. The company posted positive free cash flow of 220 million for the quarter. USD.
CFO Max Chiara commented: “Thanks to the robust cash flow generation in the quarter and since the beginning of the year, we have been able to improve our liquidity and reduce net debt. [D] Improving our profitability should support our continued focus on deleveraging. ”

7 Upcoming IPOs to monitor the price until 2021

During the quarter, the group signed a two-year contract extension with the New York Lottery. The continued reopening of casinos and betting shops should bring further tailwind for stocks. However, a possible pullback towards USD 11 would improve the margin of safety.

PPL (PPL)
Source: Shutterstock

52 week range: $ 18. $ 12- $ 36. 83
Dividend yield: 5th. 41%
PPL Corporation, headquartered in Allentown, Pennsylvania, is a utility company providing energy services to more than 10 million customers in the United States. S.. . and the U. . K. . The company generates electricity from power plants in Kentucky.
PPL published its third quarter results in early November. Sales were $ 1. 89 billion, a 2. 5% decrease from $ 1. 93 billion in the third quarter of 2019. Three segments contribute to sales, namely U. . K. . Regulated, Kentucky Regulated, and Pennsylvania Regulated Segments. Adjusted earnings were $ 450 million, or 58 cents per share. A year ago it was $ 445 million, or 61 cents a share.
Vincent Sorg, President and CEO, said:
While COVID-19 and milder weather impacted PPL’s ​​ongoing earnings in the first half of the year, we are on track to hit the lower end of our earnings forecast and have narrowed our guidance for 2020 to $ 2. $ 40 to $ 2. 50 per share from the previous range of $ 2. $ 40 to $ 2. 60 per share.
At the beginning of the year, management announced plans to sell the U.. K. . Business, a great contribution to the operation. Such a sale would allow PPL to pay off long-term debt or to buy U.. S.. . -based assets. Potential investors may therefore want to keep an eye on developments. Still, we like the stocks long term.
At the time of publication, Tezcan Gecgil had positions (neither directly nor indirectly) in the securities referred to in this article.
Tezcan Gecgil Ph. D.. . has worked in investment management in the US for over two decades. S.. . and you. K. . In addition to formal higher education in the field, she has also completed all three levels of the Chartered Market Technician (CMT) exam.
More from InvestorPlace

Why everyone is investing in 5G WRONG

Top Stock Picker Reveals Its Next 1. 000% winner

Radical new battery could degrade oil markets

The 7 best cheap stocks for December post appeared first on InvestorPlace.

Starting next year, you’ll have to pay more for Comcast services. The company will increase its prices for both cable television and the Internet. According to a price list published on Reddit, from Jan.. Effective January 2021. According to the poster, the new pricing will apply to the Chicago area, but Ars Technica has confirmed that all U.S. customers will receive price increases.

Are you looking for an alternative to low-interest savings accounts or bonds? Check out this S&P. 500 stocks that pay an annual dividend yield of over 7%.

American and Canadian governments offer many of the same types of retiree services, but the subtle differences between the two countries are worth noting.

With electric vehicle inventories and their close relatives in alternative fuels, the controversial line between « bullish » and plain bull may stretch thinner than the line between the two Koreas. The appeal from vehicle manufacturers who cannot make a profit runs practically as long as the industry list itself. There is also another company that is not affected by the profit chains: Plug Power (NASDAQ: PLUG), manufacturer of hydrogen fuel cell systems for forklifts and the like, and its overrated Plug Power inventory.
Source: Shutterstock

Given the irrational exuberance that’s a true Wall Street religion these days, Plug Power stock is up more than 700% in 2020. Here’s the thing: this is exaggerated to a degree that would make Brooklyn Bridge vendors blush. Now, of course, Plug Power is 110% legitimate. If anything, the company got off to a very difficult start after falling like a spent meteor from $ 1,500 per share in 2000.
As you’ve no doubt noticed, there doesn’t seem to be such an astronomical stock price in sight today. However, the question remains to what extent investors will push the Plug Power share forward until 2021. The rise this year was uninterrupted, and as we’ll see, Wall Street is stunned by the company in a way that suggests no one is going to rip the punch away. InvestorPlace – Stock Market News, Stock Advice & Trading Tips
Plug in the network at a glance
With his report for the third quarter on Nov.. . 9, the company announced gross bills of $ 125. 6 million, which corresponds to a growth of 106% over the previous year. This was the best run of the third quarter in the company’s history and another sign that Plug Power is growing where it needs to be. Perhaps. (Hold on, you’ll see what I mean. )

10 best stocks for investors under 30

However, the analysts seem to be convinced: Nine out of ten call it a buy. Holy hydrogen, Batman! Think of some of the most established, monstrous black companies, and you won’t find that unanimity on analyst percentage. Apple (NASDAQ: AAPL)? 21 of 39. Amazon (NASDAQ: AMZN)? 42 of 49. Did I mention Apple is the World’s Most Valuable Company, worth an amazing $ 1?. 9 trillion?
You could plug in 170 Plug Powers and still have enough spare to buy an iPhone 12 for every living soul in Teaneck, N. J. . and pay for a way to power them with hydrogen cells.
I have three words to describe this: Incredible, undeniable and (maybe) unsustainable. I mean, with all of the rosy numbers I just mentioned, the latest earnings report was a failure like a big failure. The Plug Power share recorded a loss of 11 cents per share compared to forecasts of 7 cents per share.

For those who do the math, that’s 57% less than the target. For the last quarter, analysts again forecast a loss of 7 cents per share. I can see them and investors giving Plug Power another pass when the losses are bigger. Don’t you wish the Vegas casinos were just as fun and generous if you rolled snake eyes instead of a seven?
Ignorance (plus some good news) is investor bliss
This is exactly my point: if a company is losing money, misses the street profit forecasts, and still shoots up like a hydrogen-powered rocket, what’s behind it? Quote sales forecasts and « the future of the blah blah blah sector » as you’d like. For investors, heads in the clouds don’t mean boots on the ground, and while confidence in a stock can work wonders for a young company these days, it can only go so far for Plug Power stocks.
However, shareholders looking for good news to empathize will haunt them with all the might of hungry sharks. And that news came in November. 24, when Plug Power announced it had raised approximately $ 1 billion to build a network of green hydrogen production facilities to power vehicles with fuel cells.
It doesn’t matter that Plug Power had to sell some equity for this, as I know from many startup founders. If you own and love Plug Power stocks, chances are you’ll ignore them and instead buy this line from the company’s press release from CEO Andy Marsh: “This ideally positions Plug Power to accelerate the growth of the green hydrogen economy in the US and US worldwide, a job that we accept wholeheartedly. ”
“A job that we accept with all our hearts. « Sounds like a line from the 1966 spy teledrama Mission Impossible, doesn’t it? Here’s another one that was changed a bit for our purposes, and I pray it doesn’t happen: » This stock will turn out in five Destroy seconds yourself. « (Enough of TV references from the boomer era: let’s get back to the present. )
Gamble? Or a calculated risk?
Let me be very clear: I do not doubt the stamina of the Plug Power share. Not a little. But not for its current fundamentals. As I have written many times before, I am amazed at the amount of dedication investors show to these “sans-a-profit” invoices for clean energy vehicles. You can even commit suspected fraud, own some of the evidence, and oust your founder like Nikola Corp does. (NASDAQ: NKLA) and on.

The « punishment » for Nikola’s disaster? Your stock is up 65% in two months, and General Motors (NYSE: GM) has announced its intention to sign a 10-year deal to ship your batteries anyway. Did I mention that the Nikola Two Semi won’t go into production until 2013 – if at all? If your child is caught cheating on a geometry test, don’t yell at them: get them a corner office and a six-figure job in electric vehicles.
So I can see why investors love Plug Power stocks and will continue to love them. If a company that has the integrity of bird droppings on their guard can succeed as a green vehicle player in the short term, it can be a good one too. Plug Power is an honest outfit that makes real products that inspire confidence in the industry at a time when the new Biden administration is behind their green electricity cause.
Speaking of trust, continued investment in Plug Power requires a smart investor to do more than just believe. You need to extrapolate the chart of the legal capacity, not the stock price, to 2021 and beyond. Be patient; Hydrogen fuel is the future, but it will take a lot longer to arrive than impatient market lemmings think. In the meantime, watch Plug Power stock carefully and follow relevant long-term news and quarterly reports: indeed, stay connected.
At the time of publication, Lou Carlozo held long positions in TSLA and AMZN.
More from InvestorPlace

Why everyone is investing in 5G WRONG

Top Stock Picker Reveals Its Next 1. 000% winner

Radical new battery could degrade oil markets

The Plug Power Stock post looks unstoppable, but investors need to take a close look at it. It first appeared on InvestorPlace.

Not long ago, Alibaba (NYSE: BABA) stock was a fan favorite on Wall Street. It has fallen out of favor lately, mostly on its own.
Source: zhu difeng / shutterstock. com

It is rare for management to make casual mistakes, so the reaction in Alibaba stocks has been violent. They paid dearly for a misjudgment by former CEO and co-founder Jack Ma who criticized the Chinese system. This sparked quick reprisals against the state. The BABA shareholders suffered a lot, even through no fault of their own. Fortunately, this leap creates new opportunities.
Investors have been expecting ANT Financial’s biggest IPO for months. Alibaba owns a third of the stake in it, so it was due for a big payday. Then, earlier this month, we learned without much warning that they had canceled the IPO indefinitely. In addition, it turns out that it was on the orders of President Xi of China. InvestorPlace – Stock Market News, Stock Advice & Trading Tips
It is never a good idea to fight someone who has complete control over the future of your company. Although Mr.. . Ma is no longer on active duty, with Alibaba shares rapidly losing 20% ​​of their value. First in the ANT headline, then later when the result was disappointing.
Alibaba Stock Story has a happy ending
Aside from the recent skirmishes with the Chinese government, the basic story behind Alibaba stock has never been better. Singles Day broke records again this year. Nothing is broken with the company itself. The supply is only in temporary purgatory. The sale came from fear of further action by Beijing and jerky reactions to high expectations.
Basically, it still has a relatively low price / quality ratio of 30x, and the price / quality ratio is only 8x. This is in line with most of the other giga caps in the U. . S.. . Only Amazon (NASDAQ: AMZN) has a much lower price-performance ratio. Apple (NASDAQ: AAPL), Alphabet (NASDAQ: togetL, NASDAQ: toget), and Facebook (NASDAQ: FB) have agreed to give or take Alibaba stock.

10 best stocks for investors under 30

There is no telling how the clash with China will affect the bullish thesis in the short term. I assume there will likely be no long-term consequences. We can only trade the current financial data without speculating about future action.
So far the company has executed plans flawlessly and Wall Street adopted them as its own. Last year U. . S.. . Regulators targeted Chinese IPOs but didn’t want to prevent Alibaba shares from listing here. The goal was to avoid another situation like Lukin Coffee (OTCMKTS: LKNCY). . At first it looked like it was the Starbucks hunter (NASDAQ: SBUX) in China, but it turned out to be an outright scam. Investors at home and abroad have lost a bundle.

In contrast, Alibaba fundamentals are healthier than ever and do not give the bears any reason to cut it back. The upside potential of the BABA share is definitely greater than the risk below. If the intent is to hold onto the stocks for a long time, this is a good time to start. This too will pass. While this is not a perfect first floor, it is clearly not an obvious flaw.
Good basics are still important
Click EnlargeSource: Charts by TradingView

The fundamentals are strong and the tech specs support that message. It corrected only 20% and quickly, so many of the weak hands were already falling off. What remains are a number of investors who have better conviction. This is how rallies in good stocks gain ground.
Alibaba stock is still up 27% since the start of the year and is only marginally behind the NASDAQ Composite index. This is clearly not a result of grief. Those who felt they missed it the first time when it hit $ 320 last month should consider this a gift. This is a second chance for something that has already happened once and will happen again.
There are extrinsic risks from the entire stock market. Macro conditions have not improved yet, but sentiment has recovered too well. This is entirely down to three headlines from Pfizer (NYSE: PFE), Moderna (NASDAQ: MRNA) and AstraZeneca (NASDAQ: AZN). . All three have announced incredible effectiveness of their vaccines against the Covid-19 virus. People are eager to make this a reality, and maybe too eager. This could have resulted in a system-wide foam in stock prices.

If that sugar high subsides, the downside risk of this wave is in Alibaba stock. I bet this company will continue to thrive and carry out its plans the way it was.
Follow the foam
The way up is definitely easier than the one that leads to disaster. Markets buy frothy businesses in droves. This is an indication that the good guys will eventually follow suit. There is no real fear on Wall Street. Otherwise, on a day the NASDAQ was down 1%, they wouldn’t buy up 10% of the perceived foam. .
The VIX is no longer an effective measure of fear. This is like the CPI, which tries to measure current inflation . We all know it’s there, but for some reason the dipstick broke. Caution is a good idea, but not a reason to sell Alibaba stock.
At the time of writing, Nicolas Chahine held positions (neither directly nor indirectly) in the securities identified in this article.
Nicolas Chahine is the managing director of SellSpreads. com.
More from InvestorPlace

Why everyone is investing in 5G WRONG

Top Stock Picker Reveals Its Next 1. 000% winner

Radical new battery could degrade oil markets

The Alibaba Stock Woes Won’t Last, So Stay Long In The Stocks until 2021 post first appeared on InvestorPlace.

Carnival Corporation (NYSE: CCL) stocks are down roughly 27% after the cancellation of their entire U.. S.. . Fleet until Dec. . 31. With the CDC’s No-Sail order expiring late last month, investors felt the cruise ship would quickly get the ball rolling again. So far, however, the opposite has happened and the company has no desire for a quick turnaround. With Joe Biden winning the presidency and rising Covid 19 cases worldwide, the outlook for CCL stocks is bleak.
Source: Ruth Peterkin / Shutterstock. com

The cruise industry will continue to be heavily regulated until the Covid 19 pandemic is completely under control. Cruise ships like Carnival would therefore have to operate with limited capacity and implement security protocols.
Demand for cruises should hold back as most international borders remain closed. Hence, liquidity management becomes of paramount importance to Carnival and other cruise lines. InvestorPlace – Stock Market News, Stock Advice & Trading Tips
Let’s dive a little deeper to understand the dire situation of Carnival.
Abyssal third quarter
With the ships still docked, Carnival’s third quarter results were sure to be dire. Sales decreased by 99. 5% compared to the previous year to 31 million. USD.

10 best stocks for investors under 30

Additionally, the loss for the period was $ 2. 90 billion. The company had made a profit of $ 1. 76 billion in the same period last year. The company is expected to generate 70% fewer sales this year than last year.
However, given the constraints in place, the focus is more on the liquidity position than anything else. With a monthly cash burn rate of $ 770 million, the company’s cash balance was $ 8. 2 trillion. The interest rate is expected to be 530 million in the fourth quarter. USD falling, which means the liquidity balance will drop to USD 5. 02 billion in six months.
With a capital-intensive company like Carnival, it’s hard to imagine how it could work without burning huge amounts of cash every month.
Under normal circumstances it would be enough to cover its costs with its profits. With little or no revenue, however, the company will shut down portions of its fleet and dilute existing holdings through ATM offers.
Another problem for the company is a whopping $ 26 total debt. 34 billion. The company is over-funded and many agencies have already given junk ratings. As losses grow, it becomes difficult for them to pay off the debt. The long term debt change of 1 year is an astounding 112. 7%.
Rough seas ahead
Many expected Carnival to resume operations after the CDC’s No-Sail order expired in October. 31. On 2. However, on November 11th, the company announced that its North American fleet would be discontinued by Dec.. December will remain docked. A few days later, the subsidiary Costa Cruises announced that it would suspend its cruises to Greece until December. 26th.
With the second wave really here now, things are likely to get even more difficult for Carnival and its peers. They also have Joe Biden as President-Elect of the U. . S.. . who is likely to take a more proactive approach to fighting the virus.
The lifting of the no-sail order was largely due to the Trump administration’s aggressive stance on fighting the virus. Even if the carnival starts over in early 2021, it is hard to tell when it will be operating at significant capacity.
Conclusion on CCL Stock
Carnival Corporation and other cruise lines are having a hard time resuming operations without a sail after their order expires. The rising cases of Covid 19 and the proactive stance of President-elect Joe Biden are likely to add further delays and disruptions.
Carnival’s liquidity position is of major concern given a massive cash burn rate. It will be interesting to see what capacity it will return to when it returns next year. Most likely, however, things will move very slowly, making CCL stock an extremely unattractive investment at this point.
At the time of this writing, Muslim Farooque held (neither directly nor indirectly) positions in the securities identified in this article
More from InvestorPlace

Why everyone is investing in 5G WRONG

Top Stock Picker Reveals Its Next 1. 000% winner

Radical new battery could degrade oil markets

The post Investors Should Get Off the Sinking Ship Carnival Cruise Ships Are first appeared on InvestorPlace.

From Bob Ciura with a sure dividend. The U. S.. . Equity markets have returned from their March and April lows, but the economy as a whole remains on unstable foundations. The potential for a double-dip recession could lead to another downturn in equity markets. For risk-averse investors, in this climate of uncertainty, it can make sense to buy high quality dividend stocks. For this reason, we recommend high-income investors looking for stability to consider the Dividend Aristocrats. This is an exclusive list of 65 stocks in the S&P 500 Index that have increased their dividends for at least 25 consecutive years. Such a long track record of annual dividend increases shows that a company can withstand recessions. The following three stocks are all on the Dividend Aristocrats’ list. Additionally, they boast high dividend yields that are well above the S&P 500 average, as well as reasonable valuations that could bring high total returns to investors for years to come. Undervalued Dividend Aristocrat 1: AbbVieAbbVie Inc. . (NYSE: ABBV) is a healthcare giant focused on pharmaceuticals. The single most important product is Humira, a multipurpose drug that was the top-selling drug in the world last year. AbbVie was spun off from Abbott Laboratories (ABT), the former parent company that is also a dividend aristocrat. AbbVie has done very well over the course of 2020. AbbVie had third-quarter sales of $ 12. 9 billion up 52% ​​year over year. Sales increased due to the Allergan acquisition and the growth of new products. AbbVie made $ 2. 83 per share in the third quarter, up 21% over the year-ago quarter. The company has also raised its guidance for the full year and now expects adjusted earnings per share for 2020 in a range of $ 10. $ 47 to $ 10. 49, which would make for another year of growth. AbbVie also increased its dividend by 10% in late October. The stock has a high dividend yield of 5. 3% which makes it an attractive mix of yield and growth. AbbVie stock also appears undervalued, trading at a price to earnings ratio of 9. 4 using the midpoint of the adjusted full year EPS forecast. This is a relatively small multiple for a highly profitable and growing company. AbbVie’s low rating is likely due to uncertainty about its flagship product, Humira, which is currently facing competition from biosimilars in Europe and will lose patent protection in the US. S.. . in 2023. However, AbbVie has long prepared for this by investing in its own new products and acquiring Allergan. For example, AbbVie saw strong growth from Imbruvica, which saw sales increase 9% in the most recent quarter. AbbVie also completed the $ 63 billion acquisition of Allergan, which is used to manufacture a wide range of popular aesthetic products such as botox. Our estimate of the fair value for AbbVie stock is a P / E of 10. 5, compared to a forward P / E of 8. 4th. This means that AbbVie’s rating has been expanded from 8 to 8. 4 to 10. For the next five years, total return (including EPS growth and dividends) could exceed 10% per year. Undervalued Dividend Aristocrat 2: Walgreens Boots AllianceWalgreens Boots Alliance (NYSE: WBA) is a major pharmacy retailer of nearly 19. 000 stores in 11 countries. The Walgreens Boots Alliance has annual sales of nearly $ 140 billion. Walgreens has been under pressure on many fronts, not only because of the coronavirus pandemic, but also because of a prolonged downturn in physical retail. Internet-based retailers like Amazon. com Inc (NASDAQ: AMZN) and many others have gradually taken market share from physical stores as consumers have focused on shopping online for convenience. This trend already started in 2020, and the coronavirus has only accelerated the switch to online shopping. Even so, Walgreens remains highly profitable and continues to increase sales. On the 15th. October 2020, Walgreens reported fourth quarter and full year 2020 results for the period ended March 31, 2020. August 2020. In the quarter sales increased by 2. 3% up to $ 34. 7 billion. On a share basis, adjusted EPS decreased by -28. 2% on $ 1. 02, reflecting an estimated adverse impact of $ 0. 46 from the COVID-19 pandemic. Sales increased for the fiscal year 2. 0% up to $ 139. 5 billion. Adjusted earnings per share were $ 4. 74, a 21% year-over-year decrease but ahead of the previous $ 4 forecast. $ 65 to $ 4. 70. This included an estimated amount of $ 1. 06 adverse effects of the COVID-19 pandemic. The company expects a recovery in the coming year. The forecast for the 2021 financial year envisages low single-digit growth in adjusted EPS. Continued growth in sales and earnings, albeit modest, would allow Walgreens to continue increasing its dividend each year, as it has for 45 consecutive years. Share return 4. Currently 5% and the stock appears undervalued. With a forward P / E ratio of 7. 9 Compared to our fair value estimate of 10, we believe Walgreens stock can achieve a total return of 13% to 14% annually over the next five years. Undervalued Dividend Aristocrat 3: AT&TAT&T Inc (NYSE: T) is a telecommunications giant with a wide range of services including wireless, broadband, and pay-TV. AT&T also operates the DirecTV satellite television business. The company has invested heavily in the last few years to restore growth, including the massive acquisition of Time Warner worth approx. $ 85 billion that owns several valuable media properties including HBO, CNN, and Warner Bros.. . Production company. These efforts have been slow as the coronavirus pandemic negatively impacted AT&T to begin 2020. Still, AT&T generates a high level of cash flow, which enables it to pay off debt and pay dividends to shareholders. In the third quarter of 2020, AT&T had sales of $ 42. 3 billion, along with an operating cash flow of $ 12. 1 billion. The company had a total of more than 5 million domestic cellular networks and over 1 million net postpaid additions. The takeover of Time Warner by AT&T should pay off in the long term, as AT&T offers valuable diversification. In the future, AT&T will be the owner of content alongside a distributor, which is becoming more and more important in the age of streaming and cable cutting. Another promising growth catalyst is the 5G rollout. AT&T now provides access to 5G for parts over 350 U. . S.. . Markets. AT&T continues to expect free cash flow of at least $ 26 billion for the full year. AT&T’s ratio of net debt to EBITDA was ~ 2. 66x at the end of the quarter, which indicates a manageable level of debt. This is critical to AT&T’s ability to pay its dividend, which is believed to be the primary reason it owns the stock. AT&T is currently 7. 3%, an extremely high yield considering the average yield of S&P 500 under 2%. In an environment of low interest rates, AT&T is an extremely attractive stock for value investors. Also, AT&T has increased its dividend for over 30 consecutive years. From our point of view, the stock is also significantly undervalued and is trading with a forward P / E ratio of 8. 9 versus our fair value estimate of 11. This means that a valuation extension will increase future shareholder returns by approx. 4 could increase. 6% per year for the next five years. Including the 7th. 3% dividend yield and 3% expected annual growth in earnings per share. The expected returns could reach nearly 15% over the next five years. More information from Benzinga * Click here to go to Benzinga’s option deals. * Analysts react to Gaps loss of earnings, 20% decline: Short-term visibility decreased * 50 stocks move in the lunch session on Wednesday (C) 2020 Benzinga. com. Benzinga does not offer investment advice. All rights reserved.

The mood is picking up as the Annus horribilis 2020 comes to an end. After everything we’ve been through for the past ten months, there is a feeling that it just can’t get any worse. So investors are looking forward to 2021. Two big factors for market uncertainty are on the way to solving themselves. First, COVID-19 vaccines are in the works, and two major pharmaceutical companies have announced that vaccines will be available in a few months. Second, Democrat Joe Biden will take office in the White House, with increased GOP opposition in Congress. The prospect of coronavirus relief and a divided government unable to take extreme or controversial action promises us a degree of stability that is to be welcomed. Wall Street analysts are optimistic and see that there are opportunities. We pulled in TipRanks data on three stocks that were rated as potentially strong investments by highly rated analysts. These are stocks with a buy rating and a double-digit upside potential for the coming year. LendingTree, Inc. . (TREE) First up is LendingTree, the online marketplace that connects borrowers and lenders. The company offers borrowers the opportunity to acquire competitive interest rates, loan terms, and various financing products. Offers from various funding sources include credit cards, deposit accounts and insurance products. LendingTree is based in North Carolina with offices in New York, Chicago, and Seattle. In the third quarter, the company showed mixed budget results. Sales rose sequentially by 19% to 220 million. USD – but earnings declined both sequentially and year over year. At minus $ 1. 33 earnings per share were net negative, well below the prior-year figure of $ 1. 70. The 5-star analyst Mayank Tandon, who covers this stock for Needham and a total of more than 7. 100 equity professionals rated 66 is bullish despite the recent drop following third quarter results. Commented Tandon, “[We] remain positive on TREE LT’s stock as we believe the company is well positioned to generate strong and consistent sales. Consumer sales declined 68% year-over-year as the pandemic curbed consumer credit creation, but trends improved sequentially due to better personal loan volumes and a seasonal boom in student loan business . . . «  » TREE’s diversified portfolio of private finance products and the strong mundane trends driving the shift from advertising and shopping for private finance to digital channels will help the company meet its LT growth targets, « the analyst concluded. To do this, Tandon rates TREE a Buy and sets a price target of $ 375. At current levels, his target suggests the stock will move up 44% in 2021. (To see Tandon’s track record, click here. ) LendingTree has a unanimous consensus rating for Strong Buy analysts based on 6 buy ratings set over the past week. The stock’s average target price of $ 362 implies that it has room for 39% growth from the current stock price of $ 260. 09. (See TREE stock analysis on TipRanks) Allegro MicroSystems (ALGM) Allegro MicroSystems is a semiconductor company and manufacturer of integrated circuits for sensor systems and energy technologies for analysts. The company’s products are used in the automotive and industrial sectors and include solutions for developing control systems for electric vehicles. Allegro circuit chips can also be found in data centers and green energy applications. Allegro is new to the stock markets after only going public last October. The stock debuted at $ 14 per share, and the company put 25 million shares on offer. On its first day of trading, the company closed at more than $ 17 per share and had sales of over 440 million on its IPO. USD. Since then, ALGM has gained 35% in less than four trading weeks. Vijay Rakesh, 5-star analyst at Mizuho, ​​is clearly bullish about this newly listed company. “We believe Allegro will lead the first phases of a multi-year transformation in the areas of sensor technology, vehicle electrification and power distribution. This is a key benefit of its industry leadership in magnetic sensors, a differentiated roadmap for power ICs, and a non-functional operating model. Allegro’s xMR sensors and power ICs are advancing the technology platform, enabling better performance, accuracy and control for the growing EV market and industry 4. 0 – Keys to next generation electrified powertrains, data centers and factory automation, ”wrote Rakesh. Along with his bullish comments, Rakesh gives this stock a buy recommendation and a price target of USD 28. His target implies an upside potential of ~ 17% for the next 12 months. (To see Rakesh’s track record, click here. ) Overall, this chip maker is a Wall Street favorite. Out of 6 analysts surveyed over the past 3 months, all 6 are optimistic about ALGM. With a potential return of ~ 18%, the consensus target for the stock is $ 28. 29. (See ALGM stock analysis on TipRanks) American Well (AMWL) American Well, also known as AmWell, connects patients, healthcare providers and insurers to promote high quality care outcomes in a digital world. The company has more than 55 major insurers and more than 62. 000 providers who integrate their services into their networks and thus offer access to more than 80 million potential patients. AmWell is another newcomer to the markets. Last September, the company held its IPO and raised more than $ 742 million. Over 41. 2 million shares were sold with an initial price of $ 18. That compares well to the 35 million shares and the expected price of $ 14-16 before the event. AmWell saw several gains in key metrics in the first quarter of its trading as a public company. Revenue increased 80% year over year to $ 62. 6 million. The total number of active providers – more than 62. 000 – an increase of 930% over the past year and shows strong growth for the company. And the company registered over 1. 4 million patient visits in the quarter, an increase of 450% over the same quarter last year. Pointing out the importance of network growth for AMWL, Piper Sandler’s 5-star analyst Sean Wieland writes in his note on the stock: “62. 000 providers use the AMWL network, almost ten times as much as a year ago. The increase was primarily due to providers employed by or associated with AMWL’s healthcare systems and paying customers. As the number of providers on the network increases, so does the value of the network. Network expansion makes it easier for patients to find the right provider and providers to find the right patient. Wieland rates AMWL as overweight (i. e. Buy) and his target price of $ 44 show his confidence in an upward move of 78% over the next 12 months. (To see Wieland’s track record, click here. ) Overall, AMWL’s consensus rating for moderate buys is based on 8 ratings, including 5 buys and 3 holds. The shares sell for $ 24. 71 and their average price target at $ 35. 86 corresponds to an upside potential of 45%. (See AMWL stock analysis at TipRanks. ) To find great ideas for trading stocks at attractive valuations, visit TipRanks ‘Best Stocks to Buy, a newly launched tool that brings together all of TipRanks’ stock insights. Disclaimer: The opinions expressed in this article are solely those of the presented analysts. The content is intended to be used for informational purposes only. It is very important that you do your own analysis before making any investment.

Berkshire Hathaway is the ultimate Warren Buffett stock. But is it a good buy? That is what the earnings and charts for Berkshire stock show.

In May 2019, two veteran money managers shared their philosophy with MarketWatch readers that when choosing stocks for income, investors shouldn’t focus too much on the highest dividend yields. The original article included comments from Mike Loewengart, who is now Managing Director, Investment Strategy at E-Trade (which was acquired by Morgan Stanley in October), and Lewis Altfest, President of Altfest Personal Wealth Management, which manages approximately $ 1. 4 billion for private customers in New York. Loewengart believes that a good approach for income-seeking investors is to focus on total return rather than dividend yield.

U. . S.. . The stock markets are taking a break for vacation after the Dow Jones Industrial Average recently topped $ 30 for the first time. 000 has closed.

Asian equity markets fell on Friday as questions about the effectiveness of a possible coronavirus vaccine weighed on investor optimism. The benchmarks in Tokyo, Hong Kong, Seoul and Sydney pulled back, while Shanghai rose. Investors were encouraged by reports of progress toward a potential vaccine.

Canopy Growth Corp.. . (NYSE: CGC), the Canadian cannabis and CBD products company, appears to be turning the corner. It wasn’t long ago that CGC stock was in the doldrums and the outlook was pretty dark.
Source: Shutterstock

But now it looks like the company’s outlook is much better, at least in the short term.
Additionally, CGC stock is up over 34% since Friday, November last year. 20th. And since the beginning of the year there are 12. 5%, most of it last month when it rose 25. 6%. InvestorPlace – Stock Market News, Stock Advice & Trading Tips
This was likely due to the positive news from Canopy’s Q2 annual report for the quarter ended September. 30th. In addition, the outlook for the future for CGC shares is quite good.
Sales and cash flow turnaround
Canopy reported that sales increased 77% to $ 135 million. This was the highest level of sales in the company’s history.
This was due to a larger number of stores as well as a return to demand for pre-Covid-19 cannabis products. In addition, Canopy gained market share over its competitors. Eventually it started selling a lot more cannabis and CBD products, not just its cannabis flower.

10 best stocks for investors under 30

Additionally, Canopy has partnered with Martha Stewart brands for CBD gummies and related products. In addition, distribution partnerships have been established with beer companies, including the Constellation Brands (NYSE: STZ) distribution network.
This is important as the company already has a 54% market share in ready-to-drink (RTD) THC-infused beverages in Canada. They also recently launched CBD-infused RTD drinks across Canada. Once these reach the US, the company hopes to gain significant market share as well.
Canopy is still burning cash, but the burn rate now appears to be going down with less cash outflow. For example in the six months up to September. 30, Canopy lost CAD 280. 3 million cash flow from operating activities (CFFO). That was better than last year’s six-month CFFO outflow of 372 million. CAD.
Fortunately, Canopy has enough cash to cover its cash usage until it becomes profitable. As of Sept. . 30 it was CAD 1. 72 billion in cash and securities. This was less than CAD 1. 977 billion six months ago. This implies the stake of 257 million. CAD out of business in the past six months.
Therefore, at this rate, the company could take six six month periods (3 years) before it completely consumes almost all of its cash and securities. That should be enough time for the company to create positive cash flow.
What’s next with CGC Stock?
One reason for the rise in CGC stocks is the idea that a new Biden administration could be more open to legalizing cannabis and related products. In addition, it is possible that banks can start processing goods and services related to cannabis and CBD.
More importantly, however, the prospect of Covid-19 restrictions being lifted as new vaccines are nearing approval is a catalyst that inspires people to buy more cannabis. They offer cannabis stocks like CGC under the theory that people will buy more cannabis products.
Some analysts are not as confident about the outlook for CGC stock. For example TipRanks. com reports that out of 10 analysts covering the stock over the past three months, the average target price is $ 21. 19th.
This corresponds to a decrease of 10. 7% from today’s price of $ 23. 72 (as of Nov. . 20). However, the range is between a low of $ 16. 80 and a high of $ 26. 73. Seven of the 10 analysts have a hold and two have a buy recommendation.
Marketbeat, however. com reports that 18 analysts have an average price target of $ 29. 59 for CGC shares. This represents a potential upward trend of almost 25% from today’s price.
While the outlook for CGC stocks is a bit mixed in the Wall Street community, I would argue that once there is light at the end of the tunnel, they will turn around. That light will be the prospect that the company will generate free cash flow at some point in the next year or so.
At the time of publication, Mark R. . Hake had positions (neither directly nor indirectly) in any of the securities mentioned in this article.
More from InvestorPlace

Why everyone is investing in 5G WRONG

Top Stock Picker Reveals Its Next 1. 000% winner

Radical new battery could degrade oil markets

Mark Hake runs the Total Yield Value Guide, which you can find here. Post canopy growth is reversing and CGC Stock has left a huge upward trend. It first appeared on InvestorPlace.

Back in 2012, when Jumia first came out, it was its long-term goal to become the leading e-commerce provider on the continent. If customers wanted to buy it, Jumia – often referred to as the Amazon of Africa – wanted to be able to sell it. It was similar to Amazon itself, first with books and CDs, and then with almost everything Amazon.

Massage Chair, Discounts and Allowances, Black Friday, La-Z-Boy

World News – USA – Black Friday & Cyber ​​Monday Massage Chair Deals (2020): Top La-Z – Boy & Massage Chair Sales Listed by The Consumer Post
. . Related titles :
Black Friday & offers for massage chairs on Cyber ​​Monday (2020): Top La-Z-Boy & sales of massage chairs at The . . .
Black Friday massage chair offers 2020: Best Padded, Shiatsu, La-Z-Boy & Researched further offers for massage chairs . . .
Top 10 of the best best massage chairs 2020

Ref: https://finance.yahoo.com

QU’EN PENSEZ-VOUS?

Donnez votre point de vue et aboonez-vous!

[gs-fb-comments]

Votre point de vue compte, donnez votre avis

[maxbutton id= »1″]